Cyclica spins out startup, Perturba Therapeutics, from University of Toronto
Perturba fuses AI-drug design and biological science.
Healthtech
H|T: The Healthtech Times – PointClickCare’s audacious acquisition
Plus: Remote patient monitoring is raking in venture funding.
Canadian biotech leader Clarissa Desjardins secures $63 million CAD for Congruence Therapeutics
PerkinElmer and Ipsen purchased two of Desjardins’ previous companies.
iGan Partners, Faisal Belhoul launch Arabia medtech fund with $250 million USD target
The fund has invested in Okadoc, Exact Imaging, eSight, and MolecuLight.
H|T: The Healthtech Times – Investors bet big on BenchSci
Plus: What stopped The Canadian Shield from supplying the PPE and tests Canada needs?
Gandeeva Therapeutics raises $40 million in Series A funding to scale precision imaging tech
Venture capital firms Lux Capital and Leaps by Bayer led Gandeeva’s round.
PointClickCare looks to acquire US-based Audacious Inquiry
PointClickCare claims the acquisition creates access to over 150 million people.
Optina secures up to $2.6 million from Bill Gates, Jeff Bezos-backed foundation for Alzheimer’s discovery
The funding will be used to expand the number of Optina’s clinical study sites.
Three healthtech companies hiring in Canada right now
Felix Health, CognisantMD, and Align Technology are all hiring.
What stopped The Canadian Shield from supplying the PPE and rapid tests Canada needs?
China, middle-men, and government bureaucracy.
H|T: The Healthtech Times – A bumpy ride for Peloton
Plus: Zymeworks stock hits three-year low.
AI drug discovery startup BenchSci scores $63 million Series C round led by Inovia, TCV
BenchSci says its tech is used by 16 of the top 20 pharmaceutical companies.
H|T: The Healthtech Times – Future Fertility’s AI solution
Plus: Talkspace faces class action alleging it misled investors ahead of SPAC deal.
Amplitude Ventures, AltaML pen partnership to build AI, biotech companies
The partnership gives Amplitude access to Alberta’s sizeable AI sector.
Hyivy Health secures $1.1 million in pre-seed funding to ease women’s pelvic health problems
The startup is entering clinical trials, and needs to gain regulatory approval.